China
Africa
Explore chapters and articles related to this topic
Paper 3
Published in Aalia Khan, Ramsey Jabbour, Almas Rehman, nMRCGP Applied Knowledge Test Study Guide, 2021
Aalia Khan, Ramsey Jabbour, Almas Rehman
Regarding the treatment of atopic eczema, which of the following statements is true? Steroid creams should be applied twice a day.Topical antibiotics are required in most cases.Eumovate® is the most potent steroid cream.Reducing the frequency of application of topical corti costeroids reduces their efficacy and risk of local side-effects.Once-daily application of topical corticosteroids does not seem to reduce efficacy in comparison with twice-daily application.
Women's health
Published in Gina Johnson, Ian Hill-Smith, Chirag Bakhai, The Minor Illness Manual, 2018
Gina Johnson, Ian Hill-Smith, Chirag Bakhai
Eczema Burning and itchingRedness, vesicles, crusting or scalingBase of nipple may be unaffectedSelf-care: consider allergy to creams or new food given to baby. Avoid soap, shower gel, and so forth. Apply hydrocortisone or Eumovate ointment twice daily after feeds until recovered; wipe away any remaining cream before next feed
Information on level of drugs into breastmilk
Published in Wendy Jones, Breastfeeding and Medication, 2013
Bath preparations provide hydration to the skin during soaking. Many of these preparations are used for babies suffering from dry skin. No ingredient which can affect breastmilk will be absorbed during use. Compatible with use during breastfeeding due to poor absorption through skin. Topical corticosteroids Application of topical corticosteroids is recommended to treat inflammatory conditions of the skin in particular eczema and dermatitis. Used in normal quantities (i.e. a maximum of 30g or less per week) application is unlikely to lead to systemic absorption. Potent topical corticosteroids such as Dermovate should be used sparingly for as short a time as possible. Use of less-potent corticosteroid applications to large areas of the body should be kept to a minimum accompanied by frequent application of emollient preparations. Drug choice in a mother during breastfeeding based on evidence of benefit and safety for the baby: According to maternal need, lower potency corticosteroids preferable, but no reason to stop breastfeeding if mother needs more potent products in normal amounts, but avoid skin-to-skin contact Mild corticosteroids: hydrocortisone 0.1 to 2.5% Moderate-strength corticosteroids: Betnovate RD, Eumovate Potent corticosteroids: Betamethasone 0.1%, Betnovate, Locoid, Metosyn Very potent products: Dermovate, Nerisone Forte
Pityriasis alba: toward an effective treatment
Published in Journal of Dermatological Treatment, 2022
Hossam M. Abdel-Wahab, Maha H. Ragaie
Using the lottery method, patients were randomly assigned into 4 equal groups (20 patients each), according the received topical treatment on the target lesions twice daily. Patients in group I applied Calcipotriol 0.005% cream (Calcipoheal 0.005% cream, Medizen pharmaceutical industries Co., for Advanced Pharmaceutical Industries Co. (APIC), Egypt); Group II received Tacrolimus 0.03% ointment (Tarolimus 0.03% ointment, Al Andalous Medical Company, Egypt); Group III applied topical corticosteroid; Clobetasone butyrate 0.05% cream (Eumovate Cream, GlaxoSmithKline, Egypt); meanwhile, Group IV received Placebo in the form of Petrolatum (Sigma Aldrich, USA). Any type of cleansers or cosmetic products was not allowed. Standard moisturizers with SPF 20 sunscreen were used twice daily on all lesions applied at least 30 min apart from application of the treatment. The patients were advised to record any emerging adverse effects.